We Are
- Pacira BioSciences (NASDAQ:PCRX) said it has partnered with Johnson & Johnson MedTech (NYSE:JNJ) to enhance the availability of Zilretta, a treatment designed for knee pain caused by osteoarthritis.
- This collaboration aims to utilize Johnson & Johnson’s specialized sales team to promote Zilretta to both current and potential customers, the company said.
- Zilretta is known for its extended-release formula that helps manage knee pain effectively.